Charlotte's Web (CWBHF) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
6 Apr, 2026Executive summary
The annual general and special meeting will be held virtually on May 28, 2026, with shareholders voting on key proposals including director elections, auditor appointment, and a significant transaction involving BT DE Investments Inc. (BAT), a subsidiary of British American Tobacco.
The proxy materials, including the annual report and benefit report, are distributed via notice-and-access to reduce costs and environmental impact.
The company is an emerging growth company and utilizes scaled disclosure and exemptions under the JOBS Act until at least December 31, 2027.
Voting matters and shareholder proposals
Shareholders will vote to set the number of directors at six, elect six directors, appoint PKF O'Connor Davies LLP as auditors, and approve the amendment and conversion of a C$75.3 million convertible debenture held by BAT, which could result in BAT becoming a control person with over 40% ownership.
The board recommends voting FOR all proposals.
Shareholder proposals for the next annual meeting must be submitted by December 31, 2026, and director nominations must comply with advance notice and universal proxy rules.
Board of directors and corporate governance
The board consists of six directors, with three considered independent under Nasdaq and Canadian rules.
Committees include Audit, Compensation, and Corporate Governance and Nominating, each with independent chairs.
The board has adopted a written mandate, code of ethics, and policies for director qualifications, diversity, and share ownership.
No term limits or mandatory retirement ages for directors; 50% of the board and executive officers are women.
Latest events from Charlotte's Web
- Returned to growth as the #1 CBD brand, leveraging innovation, partnerships, and regulatory momentum.CWBHF
Investor presentation26 Apr 2026 - Shareholders to vote on BAT transaction, director elections, and key governance matters.CWBHF
Proxy filing16 Apr 2026 - Key votes include director elections and a debenture amendment that may shift company control.CWBHF
Proxy filing16 Apr 2026 - BAT's investment and debenture conversion will give it 40.8% ownership and expanded governance rights.CWBHF
Proxy filing1 Apr 2026 - Debt eliminated, revenue up, and new capital positions for Medicare-driven growth.CWBHF
Q4 202531 Mar 2026 - BAT transaction and regulatory momentum drive financial and strategic transformation.CWBHF
Proxy filing31 Mar 2026 - BAT's conversion and $10M investment will eliminate $65M debt and give it 40% ownership.CWBHF
Proxy filing31 Mar 2026 - Sequential revenue growth and cost cuts support breakeven and turnaround progress.CWBHF
Q2 20242 Feb 2026 - Cost discipline, new channels, and product innovation drive improved Q4 results.CWBHF
Q4 202424 Dec 2025